LAW OFFICE OF BRODSKY & SMITH, LLC REMINDS INVESTORS OF OCTOBER 4TH DEADLINE IN CLASS ACTION AGAINST CURALEAF HOLDINGS, INC. (OTC: CURLF)

BALA CYNWYD, PA / ACCESSWIRE / September 18, 2019 / Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against Curaleaf Holdings, Inc. (“Curaleaf” or the “Company”) (OTCQX:CURLF – News) for possible breaches of Federal Securities law.

According to the filed complaint, during the class period, Curaleaf Holdings, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Curaleaf, on its website and social media pages, marketed its CBD products to be used as drugs and dietary supplements, contrary to law; (2) Curaleaf also sold unapproved animal drugs on its website; (3) such conduct would result in a warning letter from the U.S. Food and Drug Administration; and (4) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

If you purchased shares of Curaleaf between November 21, 2018 and July 22, 2019 and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. The deadline for filing is October

Read More

Scroll to Top